DiaSorin | LinkedIn
DiaSorin Molecular LLC | LinkedIn
Annual Financial Report
DiaSorin : Incorporating medium-term hiccups; but re-rating potential remains intact
COVID-19 | Updates | DiaSorin
DiaSorin - The Diagnostic Specialist
DiaSorin to buy Luminex for $1.8B - MassDevice
DiaSorin Inc. | LinkedIn
DiaSorin | Saluggia
DiaSorin | Saluggia
DiaSorin S.p.A. Completes Acquisition of the Focus Diagnostics' Molecular and Immunoassay Product Business from Quest Diagnostics
ASSEMBLEA DEGLI AZIONISTI
Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays | Scientific Reports
DiaSorin - The Diagnostic Specialist
DiaSorin Molecular LLC | LinkedIn
Homepage - DiaSorin Molecular
DIASORIN S.p.A. REPORT ON THE REMUNERATION POLICY AND FEES PAID 2020
DiaSorin : Taking on board the near-term difficulties -August 16, 2023 at 05:46 am| MarketScreener
Annual Financial Report
DiaSorin | Saluggia
DiaSorin concludes acquisition of Luminex for $1.8bn
Diasorin, il titolo vola in borsa dopo i conti del primo semestre: utili e ricavi in calo ma sopra le attese - MilanoFinanza News
DiaSorin S.p.A. (DIA) Company Information - Simply Wall St
DiaSorin Inc. | LinkedIn
COVID-19 | Updates | DiaSorin
Relazione_CG_Esercizio_31 12 2008_en
Annual Financial Report
Borsa: Milano recupera (-0,5%) con Mps, male Cnh e Diasorin - Notizie - Ansa.it
/cloudfront-us-east-2.images.arcpublishing.com/reuters/34L6IFUZ2JLLDHCVNW34Y664HE.jpg "Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters")
Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters
Liaison XL. Soluciones para el inmunodiagnóstico. - YouTube
Italian biotech company DiaSorin says its Covid-19 tests can detect omicron variant - YouTube
Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody Test - COVID-19 - mobile.Labmedica.com
DiaSorin Spa Italy - DiaSorin Molecular
DiaSorin Molecular LLC | LinkedIn
 "DiaSorin simplifies diagnostics by implementing a digital solution | Reply")
DiaSorin simplifies diagnostics by implementing a digital solution | Reply
Results | DiaSorin
Results | DiaSorin
Report on the Remuneration Policy
Shares in Diasorin surge ahead of coronavirus diagnostic test launch
DiaSorin | LinkedIn
DiaSorin - The Diagnostic Specialist
DiaSorin to Acquire Focus Diagnostics Unit for $300 Million | Clinical Lab Products
Borsa: Milano in calo (-0,45%), cede Diasorin, balza Mps - Notizie - Ansa.it
Medical Countermeasures | USA Public Health Security
DiaSorin Molecular LLC | LinkedIn
LIAISON® XL | DiaSorin
Borsa: Milano frena ancora (-1,1%), pesano Diasorin e Stellantis - Notizie - Ansa.it
DiaSorin S.p.A. (DSRL.F) Company Information - Simply Wall St
